Human CEBPA-N AML exhibits enhanced engraftment and a C/EBPα-p30-driven leukemic stem cell program
Philomina Sona Peramangalam, Mayuresh Vishwas Konde, Emin Onur Karakaslar, Sebastian Wolf, Shikan Zheng, Akmal Salimov, Sridevi Surapally, Marieke Griffioen, Tongjun Gu, Sridhar Rao, Daniel Geoffrey Tenen, Thomas Oellerich, Erik B. van den Akker, Martin Carroll, Caner Saygin, John Anto Pulikkan
This study identifies CEBPA-N-AML as having enhanced engraftment and defines a novel LSC signature in CEBPA-N-AML.
bioRxiv · Aug 4, 2026 · PreprintCancer Biology